Massachusetts Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
74,735
+925
| +1% | +$20.1K | ﹤0.01% | 782 |
|
|
2025
Q1 | $1.79M | Sell |
73,810
-1,684
| -2% | -$40.8K | ﹤0.01% | 765 |
|
|
2024
Q4 | $1.58M | Sell |
75,494
-2,253
| -3% | -$47K | ﹤0.01% | 781 |
|
|
2024
Q3 | $1.55M | Sell |
77,747
-1,883
| -2% | -$37.4K | ﹤0.01% | 756 |
|
|
2024
Q2 | $1.23M | Buy |
79,630
+2,672
| +3% | +$41.4K | ﹤0.01% | 782 |
|
|
2024
Q1 | $1.23M | Sell |
76,958
-170
| -0.2% | -$2.71K | ﹤0.01% | 768 |
|
|
2023
Q4 | $1.3M | Sell |
77,128
-2,435
| -3% | -$40.9K | ﹤0.01% | 753 |
|
|
2023
Q3 | $930K | Sell |
79,563
-3,049
| -4% | -$35.6K | ﹤0.01% | 765 |
|
|
2023
Q2 | $1.11M | Sell |
82,612
-1,945
| -2% | -$26.1K | ﹤0.01% | 743 |
|
|
2023
Q1 | $1.4M | Buy |
+84,557
| New | +$1.4M | ﹤0.01% | 730 |
|